Beyondspring Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.50

-0.04 (-2.60%)

As of Feb 8, 2:17 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +2,833.3% upside

Low Target $29.80

Average Target $44.00

High Target $55.04

Current Price $1.50

Current
$1.50

Target
$44.00

$29.80 $44.00 avg $55.04

Scenario Analysis

Bear Case

$29.80

1,886.7%

Low target

Base Case

$44.00

+2,833.3%

Avg target

Bull Case

$55.04

+3,569.3%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$43.95

-96.6% from high

52-Week Low

$34.76

+-95.7% from low

Target vs 52W High

$44.00

+0.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%